Literature DB >> 10794721

Lactoferrin binding to the rat asialoglycoprotein receptor requires the receptor's lectin properties.

D D McAbee1, X Jiang, K B Walsh.   

Abstract

Lactoferrin binds to rat hepatic lectin 1 (RHL1), the major subunit of the asialoglycoprotein (ASGP) receptor, with high affinity, by a galactose-independent mechanism. To better understand the molecular basis of this novel interaction, we compared the binding of lactoferrin and asialo-orosomucoid (ASOR) to isolated rat hepatocytes and to purified ASGP receptors as a function of pH, Ca(2+) and receptor acylation. Binding of (125)I-lactoferrin and (125)I-ASOR to isolated rat hepatocytes at 4 degrees C decreased sharply at pH<6, following similar titration curves. Binding of (125)I-lactoferrin and (125)I-ASOR to hepatocytes was Ca(2+)-dependent. Binding increased progressively at > or =300 microM CaCl(2), in the presence of 1 mM EDTA. Monensin treatment of hepatocytes, which causes hepatocytes to accumulate inactive ASGP receptors, reduced surface binding of (125)I-lactoferrin and (125)I-ASOR by 46 and 49%, respectively, with only a 16% loss of immunodetectable receptor protein from the cell surface. Finally, deacylation of purified ASGP receptors in vitro with 1 M hydroxylamine abolished receptor lectin activity as reflected by the loss of (125)I-ASOR binding as well as the complete loss of specific (125)I-lactoferrin binding. Treatment with 1 M Tris had no effect on binding of either ligand. We conclude from these data that galactose-independent lactoferrin binding to the ASGP receptor requires the receptor's carbohydrate-recognition domain to be in an active configuration. An active configuration is promoted by neutral pH and Ca(2+), and also requires the receptor subunits to be acylated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10794721      PMCID: PMC1221043     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Total cellular activity and distribution of a subpopulation of galactosyl receptors in isolated rat hepatocytes are differentially affected by microtubule drugs, monensin, low temperature, and chloroquine.

Authors:  D D McAbee; M C Lear; P H Weigel
Journal:  J Cell Biochem       Date:  1991-01       Impact factor: 4.429

2.  ATP depletion causes a reversible redistribution and inactivation of a subpopulation of galactosyl receptors in isolated rat hepatocytes.

Authors:  D D McAbee; P H Weigel
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

3.  Binding and endocytosis of apo- and holo-lactoferrin by isolated rat hepatocytes.

Authors:  D D McAbee; K Esbensen
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

4.  Conformational changes in the chicken receptor for endocytosis of glycoproteins. Modulation of ligand-binding activity by Ca2+ and pH.

Authors:  J A Loeb; K Drickamer
Journal:  J Biol Chem       Date:  1988-07-15       Impact factor: 5.157

5.  Cell culture assay of biological activity of lactoferrin and transferrin.

Authors:  S Hashizume; K Kuroda; H Murakami
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Primary structure of glycans isolated from human leucocyte lactotransferrin. Absence of fucose residues questions the proposed mechanism of hyposideraemia.

Authors:  P Derisbourg; J M Wieruszeski; J Montreuil; G Spik
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

7.  Heterogeneity of bovine lactotransferrin glycans. Characterization of alpha-D-Galp-(1-->3)-beta-D-Gal- and alpha-NeuAc-(2-->6)-beta-D-GalpNAc-(1-->4)- beta-D-GlcNAc-substituted N-linked glycans.

Authors:  B Coddeville; G Strecker; J M Wieruszeski; J F Vliegenthart; H van Halbeek; J Peter-Katalinić; H Egge; G Spik
Journal:  Carbohydr Res       Date:  1992-12-15       Impact factor: 2.104

8.  Endocytosis and degradation of bovine apo- and holo-lactoferrin by isolated rat hepatocytes are mediated by recycling calcium-dependent binding sites.

Authors:  D D McAbee; W Nowatzke; C Oehler; M Sitaram; E Sbaschnig; J T Opferman; J Carr; K Esbensen
Journal:  Biochemistry       Date:  1993-12-14       Impact factor: 3.162

9.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.

Authors:  T E Willnow; J L Goldstein; K Orth; M S Brown; J Herz
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

10.  A novel cycle involving fatty acyl-coenzyme A regulates asialoglycoprotein receptor activity in permeable hepatocytes.

Authors:  P H Weigel; J D Medh; J A Oka
Journal:  Mol Biol Cell       Date:  1994-02       Impact factor: 4.138

View more
  6 in total

1.  Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Vinod C Malshe; Vaishali Pujari; Ajit Gorakshakar; Manisha Madkaikar; Kanjaksha Ghosh; Padma V Devarajan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

2.  Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma.

Authors:  Minyan Wei; Xiucai Guo; Liuxiao Tu; Qi Zou; Qi Li; Chenyi Tang; Bao Chen; Yuehong Xu; Chuanbin Wu
Journal:  Int J Nanomedicine       Date:  2015-08-12

Review 3.  Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges.

Authors:  Monika Toporkiewicz; Justyna Meissner; Lucyna Matusewicz; Aleksander Czogalla; Aleksander F Sikorski
Journal:  Int J Nanomedicine       Date:  2015-02-17

4.  In vitro and in vivo antitumor effects of lupeol-loaded galactosylated liposomes.

Authors:  Jun Zhang; Xixi Hu; Guohua Zheng; Hui Yao; Huali Liang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  Specific capture of glycosylated graphene oxide by an asialoglycoprotein receptor: a strategic approach for liver-targeting.

Authors:  Kevin R Diaz-Galvez; Nayelli G Teran-Saavedra; Alexel J Burgara-Estrella; Daniel Fernandez-Quiroz; Erika Silva-Campa; Monica Acosta-Elias; Hector M Sarabia-Sainz; Martín R Pedroza-Montero; Jose A Sarabia-Sainz
Journal:  RSC Adv       Date:  2019-03-29       Impact factor: 4.036

Review 6.  Efficient hepatic delivery of drugs: novel strategies and their significance.

Authors:  Nidhi Mishra; Narayan Prasad Yadav; Vineet Kumar Rai; Priyam Sinha; Kuldeep Singh Yadav; Sanyog Jain; Sumit Arora
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.